Topical antifungals and the smaller niche of topical allergy remedies/antihistamines are growing in popularity in Ireland as concerns increase amongst Irish consumers regarding oral medication, particularly amongst those consumers who struggle to swallow large pills. There is also a perception amongst consumers that directly targeting a specific area with a topical treatment may produce faster and more effective results.
Nappy (diaper) rash treatments continued to be a popular form of dermatologicals in Ireland in 2019, recording stable demand amongst parents. An ongoing increase in the average unit price, which is predicted to continue over the forecast period, will not be enough to deter Irish parents from investing in their babies’ comfort, particularly as strong economic growth is now leading to increasing disposable incomes.
Salon treatments pose increasing competition to some dermatologicals in Ireland, as consumers seek expert advice on how best to address various conditions. With increasing disposable incomes, Irish consumers are investing in treating certain skin conditions with alternative methods where once they would have perceived these to be expensive; light therapy and non-invasive cosmetic surgery are two alternative treatments that are increasing in popularity.
McNeil Healthcare (Ireland) Ltd retained a narrow lead over its closest competitor Bayer Ltd in 2019. Both are leading players in their respective categories with McNeil Healthcare dominating hair loss treatments with its Regaine line and haemorrhoid treatments with Anusol, while Bayer leads topical antifungals with Canesten and nappy (diaper) rash treatments with Bepanthen.
Zovirax from GSK Consumer Healthcare continued to dominate cold sore treatments, benefiting not only from strong brand loyalty and being synonymous with cold sore treatments but also the increasing popularity of the category in 2019. Consumers who suffer from cold sores want to trust that the treatment they choose to address this issue will work rapidly due to the associated embarrassment and discomfort caused by this virus.
Medicated shampoo Nizoral, which address dandruff issues, experienced a change in national distribution when new global brand owner STADA Arzneimittel AG moved it from McNeil Healthcare to Clonmel Healthcare Ltd, which also contributed to the negative performance by the former player in 2019. Nizorel was sold by former global brand owner Johnson & Johnson in 2018 to STADA Arzneimittel AG, with the latter attempting to strengthen its overall position within consumer health, and where it is already present in dermatologicals with Hedrin in antiparasitics/lice (head and body) treatments, Polytar in medicated shampoos and Caldease in nappy (diaper) rash treatments amongst others.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Ireland with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Medicated Skin Care industry in Ireland, our research will save you time and money while empowering you to make informed, profitable decisions.
The Medicated Skin Care in Ireland market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.